Evidence map›Paper›PMID 23041627›Full record

ArticleThe Journal of clinical investigation2012

Adipocyte-derived endotrophin promotes malignant tumor progression.

Jiyoung Park, Philipp E Scherer

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 198 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
198citing papers in PubMed, 1 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

198 citing papers in PubMed, 1 synthesis or guideline pooled it, 344 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Is Adipose Tissue Inflammation the Culprit of Obesity-Associated Comorbidities?Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  16. Article
  17. Article
  18. Acute kidney injury is associated with elevated urinary endotrophin.American journal of physiology. Renal physiology · 2025
    Article
  19. The Role ofCancers · 2025
    Review
  20. Article

138 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jiyoung ParkTouchstone Diabetes Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8549, USA.
Philipp E Scherer
The University of Texas Southwestern Medical Center · US

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Novel Mechanisms Regulating the Adipocyte-Brain-Hepatocyte AxisP01DK088761 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI SCHERER, PHILIPP E · 2010 to 2019
$17.4M
Adiponectin, A Protein Secreted From Adipose TissueR01DK055758 · NIDDK · YESHIVA UNIVERSITY · PI SCHERER, PHILIPP E · 2000 to 2024
$10.9M
UT Southwestern Small Animal Imaging ResourceU24CA126608 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P., SHERRY, DEAN · 2007 to 2011
$2.3M
Mouse Phenotype Core, Project 9 of 10PL1DK081182 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI RUSSELL, DAVID W. · 2007 to 2011
$2.0M
Stromal Contributions of Adipocytes in Breast CancerR01CA112023 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SCHERER, PHILIPP E · 2005 to 2009
$1.5M
Small Animal Bioluminescence and Fluorescence Imaging System (with 3D capability)S10RR024757 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P. · 2007 to 2007
$335k
NCI NIH HHS 1P30 CA142543-01NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA112023NCI NIH HHS R01-CA112023NCI NIH HHS U24 CA126608NCRR NIH HHS 1S10RR024757NCRR NIH HHS S10 RR024757NIDDK NIH HHS DK081182NIDDK NIH HHS P01 DK088761NIDDK NIH HHS P01-DK088761NIDDK NIH HHS PL1 DK081182NIDDK NIH HHS R01 DK055758NIDDK NIH HHS R01-DK55758
6 · The paper itself

Abstract

Adipocytes represent a major cell type in the mammary tumor microenvironment and are important for tumor growth. Collagen VI (COL6) is highly expressed in adipose tissue, upregulated in the obese state, and enriched in breast cancer lesions and is a stimulator of mammary tumor growth. Here, we have described a cleavage product of the COL6α3 chain, endotrophin (ETP), which serves as the major mediator of the COL6-mediated tumor effects. ETP augmented fibrosis, angiogenesis, and inflammation through recruitment of macrophages and endothelial cells. Moreover, ETP expression was associated with aggressive mammary tumor growth and high metastatic growth. These effects were partially mediated through enhanced TGF-β signaling, which contributes to tissue fibrosis and epithelial-mesenchymal transition (EMT) of tumor cells. Our results highlight the crucial role of ETP as an obesity-associated factor that promotes tumor growth in the context of adipocyte interactions with tumor and stromal cells.

Indexed as

Cell CommunicationProteolysisAdipocytesAnimalsCell Line, TumorCollagen Type VIEndothelial CellsEpithelial-Mesenchymal TransitionFemaleFibrosisGene Expression Regulation, NeoplasticMacrophagesMammary Neoplasms, AnimalMiceNeoplasm MetastasisNeoplasm ProteinsCollagen Type VIendotrophinNeoplasm ProteinsPeptide FragmentsTransforming Growth Factor beta

Identifiers

PMID23041627
PMCPMC3484450
OpenAlexW2039694476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.